Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.

Literature DB >> 108749

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.

J J Balsara, J H Jadhav, A G Chandorkar.

Abstract

Pretreatment with quipazine, a serotonin agonist, and clomipramine, a selective serotonin neuronal uptake blocker, was found to potentiate the cataleptic effect of haloperidol in a dose-dependent manner in rats. Pretreatment with methysergide, a serotonin antagonist, reduced the cataleptic effect of haloperidol. The results indicate that the cataleptic effect of neuroleptics depends on the balance between the dopaminergic and serotonergic systems, and that the serotonergic system exerts an inhibitory influence on the dopaminergic system.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1979 PMID： 108749 DOI： 10.1007/bf00426037

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

15 in total

1. The role of 5-HT in the mechanism of amphetamine action.

Authors: D Malec; R Langwiński; A Kruszewska
Journal: Pol J Pharmacol Pharm Date: 1975-10

2. Drugs, neurotransmitters, and schizophrenia.

Authors: S H Snyder; S P Banerjee; H I Yamamura; D Greenberg
Journal: Science Date: 1974-06-21 Impact factor: 47.728

Review 3. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

Authors: S Matthysse
Journal: Fed Proc Date: 1973-02

4. Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium labelled norepinephrine, dopamine, serotonin and the precursors.

Authors: J Parizek; R Hassler; I J Bak
Journal: Z Zellforsch Mikrosk Anat Date: 1971

5. Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine.

Authors: W Kostowski; W Gumulka; A Cxlonkowski
Journal: Brain Res Date: 1972-12-24 Impact factor: 3.252

6. Similarities between the pharmacological actions of quipazine and serotonin.

Authors: E Hong; L F Sancilio; R Vargas; E G Pardo
Journal: Eur J Pharmacol Date: 1969 Impact factor: 4.432

Review 7. Serotonin and central nervous system function.

Authors: T N Chase; D L Murphy
Journal: Annu Rev Pharmacol Date: 1973 Impact factor: 13.820

8. The effects of quipazine on 5-HT metabolism in the rat brain.

Authors: M Hamon; S Bourgoin; A Enjalbert; J Bockaert; F Hery; J P Ternaux; J Glowinski
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1976-07 Impact factor: 3.000

9. Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.

Authors: S B Ross; A L Renyi
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1975

10. Behavioral changes of chronic schizophrenic patients given L-5-hydroxytryptophan.

Authors: R J Wyatt; T Vaughan; M Galanter; J Kaplan; R Green
Journal: Science Date: 1972-09-22 Impact factor: 47.728

26 in total

1. Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors: R Heintz; D E Casey
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

2. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors: A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530

3. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.

Authors: Jehangir J Balsara; Sujata A Jadhav; Rajani K Gaonkar; Ramona V Gaikwad; Jagdish H Jadhav
Journal: Psychopharmacology (Berl) Date: 2004-12-22 Impact factor: 4.530

Review 4. 5-HT2 antagonism and EPS benefits: is there a causal connection?

Authors: S Kapur
Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530

Review 5. Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors: B J Kinon; J A Lieberman
Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530

Review 6. Biochemical and behavioural properties of clozapine.

Authors: D M Coward; A Imperato; S Urwyler; T G White
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

7. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.

Authors: M L Wadenberg; S Ahlenius
Journal: J Neural Transm Gen Sect Date: 1991